These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 15465600

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells.
    Kumar V, Sercarz E.
    J Immunol; 1998 Dec 15; 161(12):6585-91. PubMed ID: 9862685
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Two-domain MHC class II molecules form stable complexes with myelin basic protein 69-89 peptide that detect and inhibit rat encephalitogenic T cells and treat experimental autoimmune encephalomyelitis.
    Burrows GG, Bebo BF, Adlard KL, Vandenbark AA, Offner H.
    J Immunol; 1998 Dec 01; 161(11):5987-96. PubMed ID: 9834080
    [Abstract] [Full Text] [Related]

  • 9. Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M).
    Kaushansky N, Eisenstein M, Oved JH, Ben-Nun A.
    Int Immunol; 2008 Nov 01; 20(11):1439-49. PubMed ID: 18801757
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oral administration of myelin basic protein is superior to myelin in suppressing established relapsing experimental autoimmune encephalomyelitis.
    Benson JM, Stuckman SS, Cox KL, Wardrop RM, Gienapp IE, Cross AH, Trotter JL, Whitacre CC.
    J Immunol; 1999 May 15; 162(10):6247-54. PubMed ID: 10229871
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fine T cell receptor repertoire analysis of spinal cord T cells responding to the major and minor epitopes of myelin basic protein during rat autoimmune encephalomyelitis.
    Matsumoto Y, Jee Y, Sugisaki M, Kim G, Tanuma N.
    J Neurosci Res; 2000 Jan 01; 59(1):145-52. PubMed ID: 10658195
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Influence of a dominant cryptic epitope on autoimmune T cell tolerance.
    Anderton SM, Viner NJ, Matharu P, Lowrey PA, Wraith DC.
    Nat Immunol; 2002 Feb 01; 3(2):175-81. PubMed ID: 11812995
    [Abstract] [Full Text] [Related]

  • 20. Possibilities and limitations in the rational design of modified peptides for T cell mediated immunotherapy.
    de Haan EC, Moret EE, Wagenaar-Hilbers JP, Liskamp RM, Wauben MH.
    Mol Immunol; 2005 Feb 01; 42(3):365-73. PubMed ID: 15589325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.